Cargando…

CARDIOVASCULAR AND MORTALITY OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS STRATIFIED BY RACE AND ETHNICITY

Detalles Bibliográficos
Autores principales:	Kwan, Jennifer, Lee, Stephen, Tao, Weiwei, Wei, Wei, Simonov, Michael, Halene, Stephanie, Hwa, John, Spatz, Erica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091439/ http://dx.doi.org/10.1016/S0735-1097(21)04405-3

Ejemplares similares

CARDIOVASCULAR AND MORTALITY OUTCOMES IN ONCOLOGY PATIENTS HOSPITALIZED WITH COVID-19
por: Kwan, Jennifer, et al.
Publicado: (2021)

SIGNIFICANT ETHNIC DIFFERENCES IN PREVALENCE, CARDIAC MANIFESTATIONS AND MORTALITY IN PATIENTS WITH MODERATE TO SEVERE COVID-19 BETWEEN MIDDLE EASTERN ARABS AND SOUTH ASIAN ETHNICITY
por: Alkindi, Fahad, et al.
Publicado: (2021)

ELEVATION OF NT-PROBNP LEVEL IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY FOR COVID-19 IN ETHNIC MINORITY COMMUNITY
por: Jadhav, Preeti, et al.
Publicado: (2021)

RISK OF CARDIOVASCULAR COMPLICATIONS IN ETHNIC MINORITIES INFECTED WITH COVID-19 - EXPERIENCE IN A MID-SIZED MIDWESTERN CITY
por: Desai, Viral, et al.
Publicado: (2021)

THE IMPACT OF THE COVID-19 PANDEMIC ON ACCESS TO CARDIOVASCULAR CARE LEADING TO INCREASED CARDIOVASCULAR MORTALITY
por: Kim, Yoo Jin, et al.
Publicado: (2022)

COVID-19: RACIAL DISPARITY AND CARDIOVASCULAR COMORBIDITIES THAT PREDICT MORTALITY
por: Omeh, Demian Jideofor, et al.
Publicado: (2021)

THE ROLE OF ABO BLOOD GROUP TYPING IN RISK STRATIFYING PATIENTS WITH THE NOVEL CORONAVIRUS 2019-NCOV
por: Shadid, Husam, et al.
Publicado: (2021)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

CARDIOVASCULAR COMPLICATIONS OF COVID-19 AND IT'S TRUE MORTALITY IN A LARGE METROPOLITAN HEALTH SYSTEM
por: Dulas, Marissa, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

EXAMINING DISPARITIES AND EXCESS CARDIOVASCULAR MORTALITY IN PREGNANT INDIVIDUALS BEFORE AND DURING THE COVID-19 PANDEMIC
por: Chahine, Nicole, et al.
Publicado: (2023)

TELEHEALTH CARE BEFORE AND DURING COVID-19: TRENDS AND QUALITY IN A LARGE HEALTH SYSTEM
por: Luna, Paulina, et al.
Publicado: (2021)

INCREASED INPATIENT MORTALITY FOR CARDIOVASCULAR PATIENTS DURING THE FIRST WAVE OF THE COVID-19 EPIDEMIC IN NEW YORK
por: Makker, Parth, et al.
Publicado: (2021)

THE ASSOCIATION OF STRUCTURAL INEQUITIES AND RACE WITH OUT-OF-HOSPITAL SUDDEN DEATH DURING THE COVID-19 PANDEMIC
por: Makker, Parth, et al.
Publicado: (2021)

INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC CHANGES IN ETHNIC MINORITY PATIENTS WITH COVID- 19 INFECTION
por: Jadhav, Preeti, et al.
Publicado: (2021)

CARDIOVASCULAR PATIENT OUTCOMES AND COMPLICATIONS AFTER SARS-COV-2 INFECTION
por: Khodaverdi, M., et al.
Publicado: (2022)

RACIAL AND ETHNIC DISPARITIES IN DELAYING OR NOT RECEIVING MEDICAL CARE DURING THE COVID-19 PANDEMIC IN THE UNITED STATES
por: Ahmed, Ahmed, et al.
Publicado: (2022)

CARDIOVASCULAR COMORBIDITIES PREDISPOSE TO CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19 INFECTION
por: Razipour, Shadi, et al.
Publicado: (2022)

OUTCOMES AND READMISSION RISK OF CRITICALLY ILL COVID-19 PATIENTS WITH CARDIOVASCULAR OUTCOMES
por: Manjappachar, Nirmala, et al.
Publicado: (2022)

COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022)

THE CONSEQUENCES OF THE LOCKDOWN ON CARDIOVASCULAR DISEASES
por: Aajal, Assia, et al.
Publicado: (2021)

HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022)

OUTCOMES OF LIFE-THREATENING CARDIOVASCULAR COMPLICATIONS AND CORONAVIRUS DISEASE 19- A COHORT STUDY
por: Khorsandi, Michael, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

THE IMPACT OF TELEHEALTH ON OUTCOMES IN CARDIOVASCULAR PATIENTS
por: Cioci, Anthony, et al.
Publicado: (2022)

PRE-EXISTING CARDIOVASCULAR DISEASE, ACUTE KIDNEY INJURY, AND CARDIOVASCULAR OUTCOMES IN HOSPITALIZED BLACKS WITH COVID-19 INFECTION
por: Egbuche, Obiora, et al.
Publicado: (2021)

OUTCOMES OF COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASE
por: Vu, Chau N., et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

PREVALENCE AND OUTCOMES OF CARDIOVASCULAR COMPLICATIONS AMONGST COVID-19 PATIENTS
por: Aedma, Surya Kiran, et al.
Publicado: (2021)

INITIAL, MAXIMUM, AND DELTA TROPONIN AND MORTALITY IN COVID-19
por: Go, Ronaldo, et al.
Publicado: (2021)

MORTALITY IN LATINOS WITH COVID-19, UNIVERSITY OF MIAMI EXPERIENCE
por: Montanez-Valverde, Raul A., et al.
Publicado: (2021)

THROMBOEMBOLIC OUTCOMES IN HOSPITALIZED PATIENTS WITH UNDERLYING CARDIOVASCULAR DISEASE AND COVID-19
por: Khairani, Candrika, et al.
Publicado: (2021)

IN-HOSPITAL OUTCOMES AMONG COVID-19 PATIENTS WITH CANCER AND CARDIOVASCULAR DISEASE
por: Tehrani, David, et al.
Publicado: (2021)

IMPACT OF COVID-19 ON CARDIOVASCULAR CLINICS: ARE WE READY FOR TELE-MEDICINE?
por: Mujtaba, Mustajab, et al.
Publicado: (2022)

ECHOCARDIOGRAPHIC AND BIOMARKER PREDICTORS FOR IN-HOSPITAL MORTALITY IN COVID-19 DISEASE
por: Gomez, Joanne Michelle D., et al.
Publicado: (2021)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

ACCURACY OF THE GRACE SCORE IN PREDICTING MORTALITY IN PATIENTS WITH COVID-19
por: Noghondar, Keyvan Amini, et al.
Publicado: (2022)

CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION AND HISTORY OF CANCER
por: Siddiqi, Hasan, et al.
Publicado: (2021)

DETERMINANTS OF TELEMEDICINE UTILIZATION IN AMBULATORY CARDIOVASCULAR CARE DURING THE COVID-19 PANDEMIC
por: Mathenge, Njambi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7l7mdod8uishr05b5fvv2n018k